HCA Healthcare (HCA) Issues FY19 Earnings Guidance

Share on StockTwits

HCA Healthcare (NYSE:HCA) updated its FY19 earnings guidance on Tuesday. The company provided EPS guidance of $9.80-10.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $10.03. The company issued revenue guidance of $50.5-51.5 billion, compared to the consensus revenue estimate of $50.77 billion.

A number of brokerages have issued reports on HCA. Oppenheimer increased their target price on shares of HCA Healthcare from $142.00 to $150.00 and gave the company an outperform rating in a report on Wednesday, January 30th. Leerink Swann increased their target price on shares of HCA Healthcare from $160.00 to $175.00 and gave the company an outperform rating in a report on Wednesday, January 30th. SunTrust Banks increased their target price on shares of HCA Healthcare to $175.00 and gave the company a buy rating in a report on Wednesday, January 30th. Stephens began coverage on shares of HCA Healthcare in a report on Monday, January 14th. They issued an overweight rating and a $143.00 target price for the company. Finally, ValuEngine cut shares of HCA Healthcare from a buy rating to a hold rating in a report on Wednesday, March 6th. Two analysts have rated the stock with a sell rating, three have given a hold rating and eighteen have issued a buy rating to the stock. HCA Healthcare presently has a consensus rating of Buy and a consensus price target of $149.18.

Shares of HCA opened at $124.09 on Thursday. HCA Healthcare has a 1-year low of $94.23 and a 1-year high of $147.42. The company has a market cap of $43.70 billion, a PE ratio of 12.70, a price-to-earnings-growth ratio of 1.06 and a beta of 0.75.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.31 by $0.66. HCA Healthcare had a net margin of 7.71% and a negative return on equity of 112.65%. The firm had revenue of $12.52 billion for the quarter, compared to analyst estimates of $12.34 billion. During the same quarter last year, the business earned $3.18 earnings per share. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. As a group, research analysts predict that HCA Healthcare will post 10.04 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Monday, June 3rd will be given a dividend of $0.40 per share. The ex-dividend date is Friday, May 31st. This represents a $1.60 dividend on an annualized basis and a yield of 1.29%. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.

In related news, SVP Deborah M. Reiner sold 466 shares of the firm’s stock in a transaction that occurred on Tuesday, February 5th. The shares were sold at an average price of $139.07, for a total transaction of $64,806.62. Following the sale, the senior vice president now owns 5,037 shares in the company, valued at $700,495.59. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jon M. Foster sold 11,640 shares of the firm’s stock in a transaction that occurred on Tuesday, February 12th. The stock was sold at an average price of $139.68, for a total transaction of $1,625,875.20. Following the sale, the insider now owns 84,492 shares in the company, valued at approximately $11,801,842.56. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 77,953 shares of company stock worth $10,867,368. 2.70% of the stock is owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4325084/hca-healthcare-hca-issues-fy19-earnings-guidance.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: What are Institutional Investors?

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Louisiana-Pacific Co.  Shares Sold by MERIAN GLOBAL INVESTORS UK Ltd
Louisiana-Pacific Co. Shares Sold by MERIAN GLOBAL INVESTORS UK Ltd
Inspired Entertainment  Downgraded by Zacks Investment Research to Sell
Inspired Entertainment Downgraded by Zacks Investment Research to Sell
Zacks: Analysts Expect Las Vegas Sands Corp.  to Announce $0.78 EPS
Zacks: Analysts Expect Las Vegas Sands Corp. to Announce $0.78 EPS
Parametrica Management Ltd Trims Stake in Prosperity Bancshares, Inc.
Parametrica Management Ltd Trims Stake in Prosperity Bancshares, Inc.
Spring Bank Pharmaceuticals  Downgraded to “Hold” at Zacks Investment Research
Spring Bank Pharmaceuticals Downgraded to “Hold” at Zacks Investment Research
Parametrica Management Ltd Invests $222,000 in Janus Henderson Group PLC
Parametrica Management Ltd Invests $222,000 in Janus Henderson Group PLC


© 2006-2019 Ticker Report